These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
498 related articles for article (PubMed ID: 28192397)
21. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. Korpal M; Lee ES; Hu G; Kang Y J Biol Chem; 2008 May; 283(22):14910-4. PubMed ID: 18411277 [TBL] [Abstract][Full Text] [Related]
22. MicroRNA-200c inhibits epithelial-mesenchymal transition, invasion, and migration of lung cancer by targeting HMGB1. Liu PL; Liu WL; Chang JM; Chen YH; Liu YP; Kuo HF; Hsieh CC; Ding YS; Chen WW; Chong IW PLoS One; 2017; 12(7):e0180844. PubMed ID: 28727734 [TBL] [Abstract][Full Text] [Related]
23. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion. Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483 [TBL] [Abstract][Full Text] [Related]
24. MiR-21-5p knockdown inhibits epithelial to mesenchymal transition in A549 lung adenocarcinoma cells by upregulating RhoB. Khair HHA; Karagöz ID Mol Biol Rep; 2024 Jul; 51(1):837. PubMed ID: 39042337 [TBL] [Abstract][Full Text] [Related]
25. Direct interaction between miR-203 and ZEB2 suppresses epithelial-mesenchymal transition signaling and reduces lung adenocarcinoma chemoresistance. Duan X; Fu Z; Gao L; Zhou J; Deng X; Luo X; Fang W; Luo R Acta Biochim Biophys Sin (Shanghai); 2016 Nov; 48(11):1042-1049. PubMed ID: 27733346 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-200b inhibits the growth and metastasis of glioma cells via targeting ZEB2. Li J; Yuan J; Yuan X; Zhao J; Zhang Z; Weng L; Liu J Int J Oncol; 2016 Feb; 48(2):541-50. PubMed ID: 26648487 [TBL] [Abstract][Full Text] [Related]
27. Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses. Chang JH; Cheng CW; Yang YC; Chen WS; Hung WY; Chow JM; Chen PS; Hsiao M; Lee WJ; Chien MH J Exp Clin Cancer Res; 2018 Aug; 37(1):199. PubMed ID: 30134935 [TBL] [Abstract][Full Text] [Related]
28. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene. Li Y; Zhang H; Li Y; Zhao C; Fan Y; Liu J; Li X; Liu H; Chen J Mol Carcinog; 2018 Jan; 57(1):125-136. PubMed ID: 28940757 [TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA urothelial cancer-associated 1 promotes bladder cancer cell migration and invasion by way of the hsa-miR-145-ZEB1/2-FSCN1 pathway. Xue M; Pang H; Li X; Li H; Pan J; Chen W Cancer Sci; 2016 Jan; 107(1):18-27. PubMed ID: 26544536 [TBL] [Abstract][Full Text] [Related]
30. miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells. Kong D; Li Y; Wang Z; Banerjee S; Ahmad A; Kim HR; Sarkar FH Stem Cells; 2009 Aug; 27(8):1712-21. PubMed ID: 19544444 [TBL] [Abstract][Full Text] [Related]
31. TGF-β1-induced EMT of non-transformed prostate hyperplasia cells is characterized by early induction of SNAI2/Slug. Slabáková E; Pernicová Z; Slavíčková E; Staršíchová A; Kozubík A; Souček K Prostate; 2011 Sep; 71(12):1332-43. PubMed ID: 21321977 [TBL] [Abstract][Full Text] [Related]
32. miR-200c modulates ovarian cancer cell metastasis potential by targeting zinc finger E-box-binding homeobox 2 (ZEB2) expression. Lu YM; Shang C; Ou YL; Yin D; Li YN; Li X; Wang N; Zhang SL Med Oncol; 2014 Aug; 31(8):134. PubMed ID: 25052237 [TBL] [Abstract][Full Text] [Related]
33. MicroRNA-200c Inhibits the Metastasis of Triple-Negative Breast Cancer by Targeting ZEB2, an Epithelial-Mesenchymal Transition Regulator. Chen H; Li Z; Zhang L; Zhang L; Zhang Y; Wang Y; Xu M; Zhong Q Ann Clin Lab Sci; 2020 Jul; 50(4):519-527. PubMed ID: 32826250 [TBL] [Abstract][Full Text] [Related]
34. A directly negative interaction of miR-203 and ZEB2 modulates tumor stemness and chemotherapy resistance in nasopharyngeal carcinoma. Jiang Q; Zhou Y; Yang H; Li L; Deng X; Cheng C; Xie Y; Luo X; Fang W; Liu Z Oncotarget; 2016 Oct; 7(41):67288-67301. PubMed ID: 27589832 [TBL] [Abstract][Full Text] [Related]
35. The miR-200 family and the miR-183~96~182 cluster target Foxf2 to inhibit invasion and metastasis in lung cancers. Kundu ST; Byers LA; Peng DH; Roybal JD; Diao L; Wang J; Tong P; Creighton CJ; Gibbons DL Oncogene; 2016 Jan; 35(2):173-86. PubMed ID: 25798833 [TBL] [Abstract][Full Text] [Related]
36. Homeobox A9 directly targeted by miR-196b regulates aggressiveness through nuclear Factor-kappa B activity in non-small cell lung cancer cells. Yu SL; Lee DC; Sohn HA; Lee SY; Jeon HS; Lee JH; Park CG; Lee HY; Yeom YI; Son JW; Yoon YS; Kang J Mol Carcinog; 2016 Dec; 55(12):1915-1926. PubMed ID: 26586336 [TBL] [Abstract][Full Text] [Related]
37. miR-200 promotes the mesenchymal to epithelial transition by suppressing multiple members of the Zeb2 and Snail1 transcriptional repressor complexes. Perdigão-Henriques R; Petrocca F; Altschuler G; Thomas MP; Le MT; Tan SM; Hide W; Lieberman J Oncogene; 2016 Jan; 35(2):158-72. PubMed ID: 25798844 [TBL] [Abstract][Full Text] [Related]
38. Role of miR-200c/miR-141 in the regulation of epithelial-mesenchymal transition and migration in head and neck squamous cell carcinoma. Tamagawa S; Beder LB; Hotomi M; Gunduz M; Yata K; Grenman R; Yamanaka N Int J Mol Med; 2014 Apr; 33(4):879-86. PubMed ID: 24424572 [TBL] [Abstract][Full Text] [Related]
39. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer. Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752 [TBL] [Abstract][Full Text] [Related]
40. PTEN Insufficiency Increases Breast Cancer Cell Metastasis In Vitro and In Vivo in a Xenograft Zebrafish Model. Chiang KC; Hsu SY; Lin SJ; Yeh CN; Pang JH; Wang SY; Hsu JT; Yeh TS; Chen LW; Kuo SF; Cheng YC; Juang HH Anticancer Res; 2016 Aug; 36(8):3997-4005. PubMed ID: 27466505 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]